News & Perspective

May 21, 2019

May 21, 2019

News Scan for May 21, 2019

Temperature-stable vaccines
Dengue on Reunion
Avian flu in Vietnam, Mexico

Sep 04, 2014

Sep 04, 2014

Flu Scan for Sep 04, 2014

GSK flu vaccine deficit
Flu vaccine in pregnant women
H3N8 spread in mammals
H5N6 in Vietnam
Flu reproduction numbers

Feb 16, 2009

Feb 16, 2009

NEWS SCAN: Human and avian H5N1, fever screening and pan flu, flu vaccine, E coli source

 

Vietnam reports new H5N1 caseA Vietnamese man has tested positive for H5N1 avian influenza, according to an Associated Press (AP) story today. The 35-year-old man from Ninh Binh province in the north developed a fever Feb. 5 after slaughtering and eating several ducks that his family had raised, said a provincial health official. If confirmed by the World Health Organization, his case would be the country's 109th overall and second this year.

Dec 22, 2008

Dec 22, 2008

EU panel supports innovative pandemic, seasonal flu vaccines

(CIDRAP News) – An H5N1 influenza vaccine made by Baxter International could become the first cell culture–based H5N1 influenza vaccine to be approved for marketing, following its endorsement by a committee of the European Medicines Agency (EMEA) last week.

Recommendations of the Committee for Medicinal Products for Human Use (CHMP) are usually followed by the EMEA within a few months.

May 19, 2008

May 19, 2008

EU approves its first prepandemic H5N1 vaccine

(CIDRAP News) – An H5N1 influenza vaccine made by the British pharmaceutical company GlaxoSmithKline (GSK) has become the first prepandemic vaccine to be licensed by the European Union (EU), the company announced today.

Apr 29, 2008

Apr 29, 2008

HHS adds H5N1 clade 2.2 vaccine to stockpile

(CIDRAP News) – The US Department of Health and Human Services (HHS) has accepted the first batch of H5N1 avian influenza vaccine based on the H5N1 variant known as clade 2.2, which has spread most widely across Asia, Europe, and Africa.

Apr 03, 2008

Apr 03, 2008

China approves its first H5N1 vaccine

(CIDRAP News) – China's State Food and Drug Administration (SFDA) yesterday approved the country's first prepandemic H5N1 influenza vaccine, an inactivated whole-virus product made by Sinovac, a Beijing-based biotechnology company.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»